#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastrointestinal neuroendocrine tumour B-cell type acute leukaemia Transitional cell carcinoma C3 glomerulopathy Hairy cell leukaemia Mantle cell lymphoma stage II Ventricular fibrillation Isodicentric chromosome 15 syndrome Narcolepsy Nasopharyngeal cancer Retinoblastoma Synovial sarcoma Neuroendocrine tumour of the lung Cholangitis sclerosing Marginal zone lymphoma refractory More trials…

    Learn about Rare Diseases

    Immunodeficiency congenital – Trials in Disease Ornithine transcarbamoylase deficiency – Diagnostics Crigler-Najjar syndrome – Life with Disease Rhabdomyosarcoma – Diagnostics Cholangitis sclerosing – Diagnostics Amyotrophic lateral sclerosis – Trials in Disease Synovial sarcoma – Trials in Disease Adrenocortical carcinoma – Treatment Congenital nephrogenic diabetes insipidus – Life with Disease Glycogen storage disease type V – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tusamitamab Ravtansine Riboflavin Bp Tovorafenib Melphalan 2,4 DICHLOROBENZYL ALCOHOL Psilocybine Lasmiditan SARACATINIB Nebivolol Viltolarsen Bay 2927088 RLY-2608 Sulfasalazine Lufepirsen Timrepigene Emparvovec Pariglasgene Brecaparvovec Levothyroxine CIRTUVIVINT Mexiletine Bgb-15025 Citrate More therapies…

    Learn about Your Condition

    Short stature Procedural pain Colour blindness Injection site pain Inborn error of metabolism Lung neoplasm malignant Post cardiac arrest syndrome Cholangiosarcoma Deafness traumatic Endometrial cancer Skin disorder Somatic symptom disorder Graft infection Exfoliation glaucoma Large cell lung cancer stage 0 More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bronchiectasis

  • Study on the Safety and Tolerability of Nebulised Sodium Nitrite Formulations in Patients with Non-Cystic Fibrosis Bronchiectasis and Pseudomonas Aeruginosa

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Sodium Nitrite
    • Salbutamol Sulfate
    Bulgaria Poland Romania

  • Study on the Effects of Itepekimab for Patients with Non-Cystic Fibrosis Bronchiectasis

    Not recruiting

    2 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Itepekimab
    Czechia Denmark France Germany Greece Italy +3

  • Study on Gremubamab for Patients with Bronchiectasis and Chronic Pseudomonas Aeruginosa Infection

    Not recruiting

    2 1
    Investigated Diseases:
    • Bronchiectasis
    • Pulmonary tuberculosis
    Investigated Drugs:
    • Gremubamab
    Spain

  • Study on the Safety and Tolerance of BI 1291583 in Adults with Cystic Fibrosis Bronchiectasis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Bronchiectasis
    • Cystic fibrosis
    Investigated Drugs:
    • Bi 1291583
    • Salbutamol Sulfate
    Belgium France Germany Italy The Netherlands Spain

  • Study on Long-Term Safety and Efficacy of BI 1291583 in Patients with Bronchiectasis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Bi 1291583
    • Salbutamol Sulfate
    Belgium Bulgaria Czechia Denmark France Germany +8
Previous Page
1 2 3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!